NanoLogix Looking for Project Partner for Ebola Detection Kits
NanoLogix Inc. is configuring its N-Assay Rapid diagnostic kits for both Ebola Virus and Enterovirus detection and identification. Until recently, NanoLogix has been focused solely on the use of their N-Assay kit for bacteria detection and identification. Now, with the recent outbreaks of both Ebola and Enterovirus there is an immediate need for configuration of the N-Assay for viruses.
NanoLogix facilities are not designed for work on viruses, for this specific project they are seeking a corporate partner with the facilities necessary to bring the new N-Assay (V) to the market as quickly as possible. We consider this a matter of national security and an emergency priority. We are in discussions with potential partners, positioned with strong ties to the US government, who understand the serious threat these viruses represent.”
The NanoLogix N-Assay (V) ELISA is one of six technologies that may be used for virus detection and identification, the N-Assay (V) has unique qualities that contribute to both its rapid detection capability and long term durability that should be attractive to personnel in both developed and remote locations interested in a screening test that may provide results for Ebola or other viral threats in 30 minutes to a few hours.
Supporting information on the N-Assay (B), used for bacterial detection and identification and evidence of the capabilities of one version of the technology can be found by following this link:
Sebastian Faro, MD, PhD, is considered one of the top experts in the world on Infectious diseases of women's reproductive systems. Dr. Faro made the following comments: "N-Assay ELISA technology has been applied to the rapid identification of specific bacteria, e.g. Streptococcus agalactiae (GBS), Neisseria gonorrhoeae, & Enterococcus faecalis. This technology has been used to rapidly identify strains that are resistant to specific antibiotics. This technology significantly reduces the time from specimen submission to identifying these bacteria and resistance to specific antibiotics. This N-Assay ELISA technology can be applied to identifying viruses and is inexpensive. This technology does not require expensive equipment which makes this technology ideal for a variety of laboratory environments.”
His presentation on the N-Assay is in the following YouTube links:
Tags: Enteroviruses, Ebola virus
Date Published: October 21, 2014
Source article link: NanoLogix, Inc. » company contact details
Amplidiag® Easy Multiplex PCR Direct from Stools Now CE-IVD Labelled
New Distributor of Mobidiag Multiplex Gastrointestinal Tests to CEE Countries
Symposium: How to Manage Viruses in the Food Industry
Accurate Molecular Diagnostics for Remote Locations - GeneXpert® Omni
Corgenix to Present Ebola Abstracts at 2015 AACC Clinical Lab Expo